Choline transporter gene variation is associated with attention-deficit hyperactivity disorder

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Acetylcholine (ACh) is a neurotransmitter vital for motor control, attention, and memory.
• Dysfunction in the cholinergic system is implicated in various neurological and psychiatric disorders, including ADHD.
• The presynaptic choline transporter (CHT, SLC5A7) is crucial for regulating ACh synthesis and is upregulated during attention-demanding tasks.

Purpose of the Study:

• To investigate the association between functional choline transporter (CHT) gene variants and the risk of Attention-Deficit Hyperactivity Disorder (ADHD).
• To explore the potential role of cholinergic system deficits in ADHD pathogenesis.

Main Methods:

• A case-control study was conducted on pediatric ADHD subjects and healthy controls.
• Two CHT gene polymorphisms (Ile89Val and a 3' genomic SNP rs333229) were genotyped.
• Family-based association tests were performed on a separate cohort to validate findings and assess allele overtransmission.

Main Results:

• The Val89 allele of the CHT gene showed a 2-3 fold elevation in ADHD cases compared to controls (P=0.02).
• A significant decrease in the minor allele of the 3'SNP was observed in Caucasian male ADHD subjects (P=0.004).
• Family-based tests revealed significant overtransmission of the Val89 variant to children with ADHD Combined subtype (OR=3.16, P=0.01).

Conclusions:

• The study provides evidence linking specific CHT gene variants to an increased risk of ADHD, particularly the Combined subtype.
• These findings suggest a potential role for cholinergic deficits in ADHD.
• Further research replicating these results may support the exploration of cholinergic agonist therapies for ADHD.